• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Investig . Chest CT severity score and radiological patterns as predictors of disease severity, ICU admission, and viral positivity in COVID-

tetano

Editor, Senior Moderator
Respir Investig


. 2021 Mar 19;S2212-5345(21)00040-X.
doi: 10.1016/j.resinv.2021.02.008. Online ahead of print.
Chest CT severity score and radiological patterns as predictors of disease severity, ICU admission, and viral positivity in COVID-19 patients


Ioannis Bellos[SUP] 1 [/SUP], Kyriaki Tavernaraki[SUP] 2 [/SUP], Konstantinos Stefanidis[SUP] 3 [/SUP], Olympia Michalopoulou[SUP] 1 [/SUP], Giota Lourida[SUP] 1 [/SUP], Eleni Korompoki[SUP] 4 [/SUP], Ioanna Thanou[SUP] 5 [/SUP], Loukas Thanos[SUP] 5 [/SUP], Angelos Pefanis[SUP] 1 [/SUP], Aikaterini Argyraki[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Chest computed tomography (CT) is a useful tool for the diagnosis of coronavirus disease-2019 (COVID-19), although its exact value for predicting critical illness remains unclear. This study evaluated the efficacy of chest CT to predict disease progression, pulmonary complications, and viral positivity duration.
Methods: A single-center cohort study was conducted by consecutively including hospitalized patients with confirmed COVID-19. The chest CT patterns were described and a total severity score was calculated. The predictive accuracy of the severity score was evaluated using the receiver operating characteristic analysis, while a Cox proportional hazards regression model was implemented to identify the radiological features that are linked to prolonged duration of viral positivity.
Results: Overall, 42 patients were included with 10 of them requiring intensive care unit admission. The most common lesions were ground glass opacities (92.9%), consolidation (66.7%), and crazy-paving patterns (61.9%). The total severity score significantly correlated with inflammatory and respiratory distress markers, as well as with admission CURB-65 and PSI/PORT scores. It was estimated to predict critical illness with a sensitivity and specificity of 75% and 70%, respectively. Time-to-event analysis indicated that patients without ground-glass opacities presented significantly shorter median viral positivity (16 vs. 27 days).
Conclusions: Chest CT severity score positively correlates with markers of COVID-19 severity and presents promising efficacy in predicting critical illness. It is suggested that ground-glass opacities are linked to prolonged viral positivity. Further studies should confirm the efficacy of the severity score and elucidate the long-term pulmonary effects of COVID-19.

Keywords: COVID-19; Chest; Computed tomography; Critical illness; Predict.
 
Back
Top Bottom